(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: HEALTHCARE: Michael Rea, CEO of Rx Savings Solutions, to discuss the wide gap in Mylan's EpiPen drug pricing between the UK ($69) and the US ($600.)

Apple Slides Most Since 2025 After Supply Shortages Hurt Outlook
17:44

Instant Reaction: Apple Slides After Supply Shortages Hurt Its Sales Forecast
10:27

Instant Reaction: Amazon Reports Cloud Sales Growth for Fifth Straight Quarter
18:09